Net Income (Loss) Attributable to Parent in USD of Endo International plc from 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Endo International plc quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2012 to Q4 2023.
  • Endo International plc Net Income (Loss) Attributable to Parent for the quarter ending 31 Dec 2023 was -$2.44B, a 903% decline year-over-year.
  • Endo International plc Net Income (Loss) Attributable to Parent for the twelve months ending 31 Dec 2023 was -$2.45B, a 16.2% increase year-over-year.
  • Endo International plc annual Net Income (Loss) Attributable to Parent for 2023 was -$2.45B, a 16.2% increase from 2022.
  • Endo International plc annual Net Income (Loss) Attributable to Parent for 2022 was -$2.92B, a 377% decline from 2021.
  • Endo International plc annual Net Income (Loss) Attributable to Parent for 2021 was -$613M, a 433% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Endo International plc Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$2.45B -$2.44B -$2.2B -903% 01 Oct 2023 31 Dec 2023 10-K 06 Mar 2024
Q3 2023 -$252M -$28.5M +$694M +96.1% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2023
Q2 2023 -$946M $23.4M +$1.91B 01 Apr 2023 30 Jun 2023 10-Q 06 Nov 2023
Q1 2023 -$2.85B -$3.28M +$68.7M +95.4% 01 Jan 2023 31 Mar 2023 10-Q 06 Nov 2023
Q4 2022 -$2.92B -$244M +$319M +56.7% 01 Oct 2022 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 -$3.24B -$722M -$645M -835% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 -$2.6B -$1.89B -$1.87B -12064% 01 Apr 2022 30 Jun 2022 10-Q 06 Nov 2023
Q1 2022 -$727M -$72M -$113M -273% 01 Jan 2022 31 Mar 2022 10-Q 06 Nov 2023
Q4 2021 -$613M -$562M -$681M -571% 01 Oct 2021 31 Dec 2021 10-K 06 Mar 2024
Q3 2021 $68.2M -$77.2M -$1.32M -1.74% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $69.5M -$15.5M -$26.1M -247% 01 Apr 2021 30 Jun 2021 10-Q 09 Nov 2022
Q1 2021 $95.5M $41.5M -$88.4M -68% 01 Jan 2021 31 Mar 2021 10-Q 09 Nov 2022
Q4 2020 $184M $119M +$338M 01 Oct 2020 31 Dec 2020 10-K 26 Feb 2021
Q3 2020 -$154M -$75.9M +$3.53M +4.44% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021
Q2 2020 -$158M $10.6M +$117M 01 Apr 2020 30 Jun 2020 10-Q 05 Nov 2021
Q1 2020 -$274M $130M +$149M 01 Jan 2020 31 Mar 2020 10-Q 05 Nov 2021
Q4 2019 -$423M -$219M +$73.3M +25.1% 01 Oct 2019 31 Dec 2019 10-K 26 Feb 2021
Q3 2019 -$496M -$79.4M +$93.8M +54.2% 01 Jul 2019 30 Sep 2019 10-K 26 Feb 2021
Q2 2019 -$590M -$106M -$45.1M -74.2% 01 Apr 2019 30 Jun 2019 10-K 26 Feb 2021
Q1 2019 -$545M -$18.6M +$487M +96.3% 01 Jan 2019 31 Mar 2019 10-K 26 Feb 2021
Q4 2018 -$1.03B -$292M +$76.5M +20.8% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2020
Q3 2018 -$1.11B -$173M -$76.5M -79.2% 01 Jul 2018 30 Sep 2018 10-K 26 Feb 2020
Q2 2018 -$1.03B -$60.9M +$1.34B +95.6% 01 Apr 2018 30 Jun 2018 10-K 26 Feb 2020
Q1 2018 -$2.37B -$505M -$332M -191% 01 Jan 2018 31 Mar 2018 10-K 26 Feb 2020
Q4 2017 -$2.04B -$368M +$2.97B +89% 01 Oct 2017 31 Dec 2017 10-K 28 Feb 2019
Q3 2017 -$5B -$96.7M +$122M +55.8% 01 Jul 2017 30 Sep 2017 10-K 28 Feb 2019
Q2 2017 -$5.13B -$1.4B -$1.74B -506% 01 Apr 2017 30 Jun 2017 10-K 28 Feb 2019
Q1 2017 -$3.39B -$174M -$40M -29.8% 01 Jan 2017 31 Mar 2017 10-K 28 Feb 2019
Q4 2016 -$3.35B -$3.34B -$3.22B -2718% 01 Oct 2016 31 Dec 2016 8-K 08 May 2018
Q3 2016 -$128M -$219M +$832M +79.2% 01 Jul 2016 30 Sep 2016 8-K 08 May 2018
Q2 2016 -$959M $344M +$594M 01 Apr 2016 30 Jun 2016 8-K 08 May 2018
Q1 2016 -$1.55B -$134M -$58.2M -76.8% 01 Jan 2016 31 Mar 2016 8-K 08 May 2018
Q4 2015 -$1.5B -$118M -$65M -121% 01 Oct 2015 31 Dec 2015 10-K 01 Mar 2017
Q3 2015 -$1.43B -$1.05B -$798M -317% 01 Jul 2015 30 Sep 2015 10-K 01 Mar 2017
Q2 2015 -$632M -$250M -$272M -1283% 01 Apr 2015 30 Jun 2015 10-K 01 Mar 2017
Q1 2015 -$360M -$75.7M +$361M +82.7% 01 Jan 2015 31 Mar 2015 10-K 01 Mar 2017
Q4 2014 -$721M -$53.5M +$722M +93.1% 01 Oct 2014 31 Dec 2014 10-K 29 Feb 2016
Q3 2014 -$1.44B -$252M -$292M -727% 01 Jul 2014 30 Sep 2014 10-K 29 Feb 2016
Q2 2014 -$1.15B $21.2M -$13.8M -39.5% 01 Apr 2014 30 Jun 2014 10-K 29 Feb 2016
Q1 2014 -$1.14B -$437M -$452M -2947% 01 Jan 2014 31 Mar 2014 10-K 29 Feb 2016
Q4 2013 -$685M -$776M 01 Oct 2013 31 Dec 2013 8-K 02 Jun 2015
Q3 2013 $40.2M 01 Jul 2013 30 Sep 2013 8-K 02 Jun 2015
Q2 2013 $35M 01 Apr 2013 30 Jun 2013 8-K 02 Jun 2015
Q1 2013 $15.3M 01 Jan 2013 31 Mar 2013 8-K 02 Jun 2015

Endo International plc Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2.45B +$473M +16.2% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2024
2022 -$2.92B -$2.31B -377% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024
2021 -$613M -$797M -433% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2024
2020 $184M +$607M 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023
2019 -$423M +$609M +59% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
2018 -$1.03B +$1B +49.3% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021
2017 -$2.04B +$1.31B +39.2% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020
2016 -$3.35B -$1.85B -124% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019
2015 -$1.5B -$774M -107% 01 Jan 2015 31 Dec 2015 8-K 08 May 2018
2014 -$721M -$36M -5.25% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017
2013 -$685M +$55M +7.43% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 -$740M 01 Jan 2012 31 Dec 2012 8-K 02 Jun 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.